Dysbindin modulates brain function during visual processing in children

NeuroImage

Volumn 49, Issue 1, 2010, Pages 817-822

  Mechelli, A ^a   Viding, E ^a,b   Kumar, A ^a   Pettersson Yeo, W ^a   Fusar Poli, P ^a   Tognin, S ^a   O'Donovan, M C ^c   McGuire, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Children; Dysbindin; Functional Magnetic Resonance Imaging; Schizophrenia; Visual processing

Indexed keywords

DYSBINDIN;

ALLELE; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CHILD; CONTROLLED STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; NORMAL HUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SCHOOL CHILD; STATISTICAL ANALYSIS; TASK PERFORMANCE; VISUAL SYSTEM;

ALLELES; BRAIN; CARRIER PROTEINS; CHILD; COGNITION; DNA; GENE EXPRESSION; GENOTYPE; HAPLOTYPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; OCCIPITAL LOBE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; RISK; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VISUAL PERCEPTION;

EID: 70349976762     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.07.030     Document Type: Article

References (49)

1. Addington A.M., Gornick M.C., Shaw P., Seal J., Gogtay N., Greenstein D., et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol. Psychiatry 12 2 (2007) 195-205
2. Bitan T., Cheon J., Lu D., Burman D.D., and Booth J.R. Developmental increase in top-down and bottom-up processing in a phonological task: an effective connectivity, fMRI study. J. Cogn. Neurosci. 21 6 (2009) 1135-1145
3. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., et al. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 14 14 (2005) 1947-1954
4. Breceli J. From immature to mature pattern ERG and VEP. Doc. Ophthalmol. 107 3 (2003) 215-224 Review
5. Burdick K.E., Lencz T., Funke B., Finn C.T., Szeszko P.R., Kane J.M., et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 15 10 (2006) 1563-1568
6. Burdick K.E., Goldberg T.E., Funke B., Bates J.A., Lencz T., Kucherlapati R., et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 89 1-3 (2007) 169-172
7. Burgund E.D., Kang H.C., Kelly J.E., Buckner R.L., Snyder A.Z., Petersen S.E., et al. The feasibility of a common stereotactic space for children and adults in fMRI studies of development. Neuroimage 17 1 (2002) 184-200
8. Butler P.D., and Javitt D.C. Early-stage visual processing deficits in schizophrenia. Curr. Opin. Psychiatry 18 2 (2005) 151-157
9. Butler P.D., Zemon V., Schechter I., Saperstein A.M., Hoptman M.J., Lim K.O., et al. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch. Gen. Psychiatry 62 5 (2005) 495-504
10. Craddock N., O'Donovan M.C., and Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42 3 (2005) 193-204
11. Donohoe G., Morris D.W., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 45 2 (2007) 454-458
12. Donohoe G., Morris D.W., De Sanctis P., Magno E., Montesi J.L., Garavan H.P., et al. Early visual processing deficits in dysbindin-associated schizophrenia. Biol Psychiatry 63 5 (2008) 484-489
13. Fallgatter A.J., Herrmann M.J., Hohoff C., Ehlis A.C., Jarczok T.A., Freitag C.M., et al. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology 31 9 (2006) 2002-2010
14. Freeman B., Smith N., Curtis C., Huckett L., Mill J., and Craig I.W. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav. Genet. 33 (2003) 67-72
15. Friston K.J. Introduction: experimental design and statistical parametric mapping. In: Frackowiak R.S.J., Friston K.J., Frith C., Dolan R., Friston K.J., Price C.J., Zeki S., Ashburner J., and Penny W.D. (Eds). Human Brain Function (2003), Academic Press 599-632
16. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch. Gen. Psychiatry 61 2 (2004) 177-183
17. Goodman R., Ford T., Simmons H., Gatward R., and Meltzer H. Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Br. J. Psychiatry 177 (2000) 534-539
18. Gornick M.C., Addington A.M., Sporn A., Gogtay N., Greenstein D., Lenane M., et al. Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J. Autism. Dev. Disord. 35 6 (2005) 831-838
19. Harrison P., and Weinberger D. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 1 (2005) 40-68
20. Kang H.C., Burgund E.D., Lugar H.M., Petersen S.E., and Schlaggar B.L. Comparison of functional activation foci in children and adults using a common stereotactic space. Neuroimage 19 1 (2003) 16-28
21. Kim-Cohen J., Caspi A., Moffitt T.E., Harrington H., Milne B.J., and Poulton R. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. Arch. Gen. Psychiatry 60 7 (2003) 709-717
22. Kirov G., Ivanov D., Williams N.M., Preece A., Nikolov I., Milev R., et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry 55 10 (2004) 971-975
23. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., et al. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol. Psychiatry 63 2 (2008) 191-196
24. Li T., Zhang F., Liu X., Sun X., Sham P.C., Crombie C., et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol. Psychiatry 10 (2005) 1037-1044
25. Logothetis N.K., Pauls J., Augath M., Trinath T., and Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 412 6843 (2001) 128-130
26. Martínez A., Hillyard S.A., Dias E.C., Hagler Jr. D.J., Butler P.D., Guilfoyle D.N., et al. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J. Neurosci. 28 30 (2008) 7492-7500
27. Mechelli A., Henson R.N., Price C.J., and Friston K.J. Comparing event-related and epoch analysis in blocked design fMRI. Neuroimage 18 3 (2003) 806-810
28. Mechelli A., Prata D.P., Fu C.H., Picchioni M., Kane F., Kalidindi S., et al. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 42 2 (2008) 817-826
29. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13 21 (2004) 2699-2708
30. Oord E., Sullivan P., Jiang Y., Walsh D., O'Neill F., Kendler K., et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry 8 (2003) 499-510
31. Owen M.J., Craddock N., and O'Donovan M.C. Schizophrenia: genes at last?. Trends Genet. 21 9 (2005) 518-525
32. Owen M.J., Craddock N., and Jablensky A. The genetic deconstruction of psychosis. Schizophr. Bull. 33 4 (2007) 905-911
33. Penny W.D., and Holmes A. Random effects analysis. In: Frackowiak R.S.J., Friston K.J., Frith C., Dolan R., Friston K.J., Price C.J., Zeki S., Ashburner J., and Penny W.D. (Eds). Human Brain Function (2003), Academic Press 843-850
34. Piskulic D., Olver J.S., Norman T.R., and Maruff P. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res. 150 2 (2007) 111-121 Review
35. Raybould R., Green E.K., MacGregor S., Gordon-Smith K., Heron J., Hyde S., et al. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol. Psychiatry 57 7 (2005) 696-701
36. Ross C., Margolis R., Reading S., Pletnikov M., and Coyle J. Neurobiology of Schizophrenia. Neuron 52 1 (2006) 139-153
37. Schechter I., Butler P.D., Silipo G., Zemon V., and Javitt D.C. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophr. Res. 64 2-3 (2003) 91-101
38. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 1 (2003) 185-190
39. Straub R., Jiang Y., MacLean C., Ma Y., Webb B., Myakishev M., et al. Genetic variation in 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71 2 (2002) 337-348
40. Talbot K., Eidem W., Tinsley C., Benson M., Thompson E., Smith R., et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113 9 (2004) 1353
41. Tang J., Zhou J., Li X., Shi Y., Gu N., Feng G., et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol. Psychiatry 8 12 (2003) 717-718
42. Tochigi M., Zhang X., Ohashi J., Hibino H., Otowa T., Rogers M., et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci. Res. 56 2 (2006) 154-158
43. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B 5 (2007) 647-659
44. Van Den Bogaert A., Schumacher J., Schulze T.G., Otte A.C., Ohlraun S., Kovalenko S., et al. The DTNPB1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 73 6 (2003) 1438-1443
45. Viding E., Williamson D.E., and Hariri A.R. Developmental imaging genetics: challenges and promises for translational research. Dev. Psychopathol. 18 3 (2006) 877-892 Review
46. Wechsler D. Wechsler Abbreviated Scale of Intelligence (1999), Psychological Corporation
47. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 7 (1987) 660-669
48. Whittingstall K., Stroink G., and Schmidt M. Evaluating the spatial relationship of event-related potential and functional MRI sources in the primary visual cortex. Hum. Brain Mapp. 28 2 (2007) 134-142
49. Williams N.M., Preece A., Morris D.W., Spurlock G., Bray N.J., Stephens M., et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry 61 4 (2004) 336-344